FDA Hits UK Drugmaker for CAPAs, Records

Drug Industry Daily
A A
The FDA flagged deficiencies in corrective actions, testing and documentation during a July/August inspection of UK drug substance and sterile drugmaker Porton Biopharma.

To View This Article:

Login

Subscribe To Drug Industry Daily